BRIEF published on 03/18/2025 at 18:05, 8 months 17 days ago Oxurion Announces Transparency Updates Regarding Atlas Special Opportunities Atlas Special Opportunities Oxurion Belgian Legislation Transparency Notifications Voting Securities
PRESS RELEASE published on 03/18/2025 at 18:00, 8 months 17 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC Oxurion NV receives transparency notifications from Atlas Special Opportunities, LLC regarding selling of voting securities, crossing thresholds. Developing ophthalmic therapies for retinal disease Atlas Special Opportunities Ophthalmic Therapies Oxurion NV Retinal Disease Transparency Notifications
BRIEF published on 03/04/2025 at 19:05, 9 months ago Oxurion Extends Financing Agreement With Atlas Convertible Bonds Market Capitalization Atlas Special Opportunities Oxurion Financing Program
PRESS RELEASE published on 03/04/2025 at 19:00, 9 months ago Oxurion Extends Its Financing Program Oxurion NV signs third amendment to convertible bond subscription agreement with Atlas Special Opportunities II, LLC, extending issuance period and clarifying maturity terms Amendment Convertible Bond Oxurion NV Atlas Special Opportunities II Financing Terms
BRIEF published on 02/14/2025 at 19:05, 9 months 18 days ago Oxurion Enhances Board with Nelly Souleymane's Appointment Innovation Board Changes Biopharmaceutical Diversity Oxurion
PRESS RELEASE published on 02/14/2025 at 19:00, 9 months 18 days ago Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane Oxurion NV announces changes in Board of Directors with the departure of two members and the integration of Nelly Souleymane, strengthening governance and strategic expertise in communication Board Of Directors Governance Communication Oxurion NV Nelly Souleymane
BRIEF published on 01/20/2025 at 18:05, 10 months 15 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Notification Share Acquisition Atlas Special Opportunities Oxurion Retinal Disease Therapies
PRESS RELEASE published on 01/20/2025 at 18:00, 10 months 15 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities, LLC, crossing the 20% threshold. Company engaged in developing ophthalmic therapies Transparency Notification Ophthalmic Therapies Oxurion NV Shares Ownership Belgian Transparency Legislation
BRIEF published on 01/14/2025 at 18:05, 10 months 21 days ago Oxurion Receives Transparency Update from Atlas Special Opportunities LLC Actions Transparency Atlas Biopharmaceutical Oxurion
PRESS RELEASE published on 01/14/2025 at 18:00, 10 months 21 days ago Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC Oxurion NV announces receiving an amended transparency notification regarding share ownership by Atlas Special Opportunities, LLC, crossing under the 3% threshold Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Retinal Disease
Published on 12/05/2025 at 02:35, 6 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:30, 39 minutes ago Dahua Technology Celebrates Pro Challenge 2025 to Deepen Global Installer Ecosystem Collaboration
Published on 12/05/2025 at 08:30, 39 minutes ago Premier Miton Global Renewables Trust PLC - Suspension
Published on 12/05/2025 at 08:05, 1 hour 4 minutes ago Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 1 hour 8 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 1 hour 8 minutes ago Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:45, 24 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
